IGPA Files Recommendations for USTR 2015 Special 301 Review

February 13, 2015 – IGPA has filed its inaugural submission with the Office of the United States Trade Representative (USTR) as part of USTR`s 2015 Special 301 Review. The IGPA submission identifies a number of trade barriers and impediments for the generic pharmaceutical and biosimilar medicines industries.


Growing support for shared ethical principles from healthcare and medicines providers

January 26, 2015 - The International Hospital Federation (IHF) and the International Generic Pharmaceutical Alliance (IGPA) endorse efforts by organizations representing patients, health professionals and R&D pharma to recognize common ethical principles worldwide when delivering solutions to address patients’ needs. Global movement fostering ethical practices celebrates first anniversary of its Consensus Framework, showing progress at national level. The Consensus Framework can be referred to by health providers and has the potential to impact millions of patients worldwide.


17th Annual IGPA Conference to Feature Global Generic Drug Industry Experts

MIAMI, FLORIDA (November 19, 2014) — Today, the International Generic Pharmaceutical Alliance (IGPA) commences its 17th Annual Conference, bringing together company executives, regulators, national authorities and other global leaders in the generic drug industry.

Contact Info


Rue des Pierres-du-Niton 17
1207 Geneva

Telephone: +32 (0)2 5346607
This email address is being protected from spambots. You need JavaScript enabled to view it.  
This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site